Search the Newsreel

Curium strikes up to $8 billion deal for radiopharma peer Lantheus

Curium has agreed to acquire radiopharmaceutical company Lantheus Holdings in a deal valued at up to $8 billion. Lantheus shareholders will receive $102.50 per share in cash, with potential additional payments of up to $12 per share based on sales targets, representing a 14.9% …

Lantheus Holdings Inc Revenue Breakdown – SWB:0L8

Lantheus Holdings Inc (SWB:0L8) generated €1.31 billion in revenue last year, with its PYLARIFY segment being the top performer, contributing €842.15 million. The United States was the largest geographical contributor, accounting for €1.24 billion of the total revenue. These figures show a slight increase …

Lantheus Holdings (LNTH) Pipeline Narrative Holds Firm, Does The Stock Look Fully Valued?

Lantheus Holdings (LNTH) shares recently closed at US$101, showing a strong year-to-date return of 50.14% despite a recent 9% dip. The company is considered 3% undervalued with a fair value of $104 per share, driven by an expanding radiodiagnostic pipeline including multiple new product …

Lantheus Holdings (LNTH): Vanguard Portfolio Management reports 5.06% ownership stake

Vanguard Portfolio Management has reported a 5.06% ownership stake in Lantheus Holdings Inc. (LNTH) through a Schedule 13G SEC filing. This filing indicates beneficial ownership of 3,300,293 shares as of June 30, 2026, with Vanguard holding sole voting power over 61,822 shares and sole …

ETFs Investing in Lantheus Holdings Inc Stocks

This article lists various Exchange Traded Funds (ETFs) that hold stocks of Lantheus Holdings Inc. The ETFs are sorted by market value and provide details such as issuer, management style, focus, expense ratio, AUM, price, and 3-year total return. This information helps investors identify …

Curium Reportedly Nears Acquisition Of Lantheus For Approximately $7 Billion

Curium Pharma is reportedly in advanced discussions to acquire radiopharmaceutical company Lantheus Holdings for approximately $7 billion, with potential for up to $8 billion through contingent value rights. This acquisition would merge two major nuclear medicine and diagnostic imaging companies, aiming to create a …

LNTH Maintained by Mizuho -- Price Target Lowered to $115

Mizuho maintained an "Outperform" rating for Lantheus Holdings (LNTH) but lowered its price target from $120 to $115. GuruFocus indicates that LNTH is currently 9.8% overvalued with a GF Value™ of $90.52 and a strong GF Score™ of 79/100, driven by high profitability and …

LNTH|Lantheus Holdings Inc|Price:102.540|Chg%:-5.490

This article provides a comprehensive stock analysis of Lantheus Holdings Inc (LNTH) by TradingKey, highlighting its strong fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. Despite recent weak market performance, the company exhibits robust fundamentals and is considered …

Lantheus (LNTH) to Release Earnings on Wednesday

Lantheus Holdings, Inc. Stock 12‑Month Price Target Raised to $113.82, Implies 5% Upside

Lantheus Holdings, Inc. (LNTH) has seen its average 12-month price target raised to $113.82 by 11 analysts, up from $112.91. This new target suggests a potential 5% upside based on the July 27 closing price. The consensus analyst rating remains a "Buy" across 14 …

LNTH Stock Drops After-Hours As Curium's $7B Offer Comes In Below Market Value

Shares of Lantheus Holdings Inc. (LNTH) dropped 3% in after-hours trading following reports that Curium is in advanced talks to acquire the radiopharmaceutical firm for $7 billion. The offer, which includes an upfront payment of roughly $102 per share plus contingent value rights, is …

Curium in talks to buy Lantheus Holdings for about $7B - Bloomberg (LNTH:NASDAQ)

Curium, backed by CapVest Partners, is reportedly in advanced discussions to acquire radiopharma company Lantheus Holdings (LNTH) for approximately $7 billion. The deal is expected to be announced soon, with Curium offering an upfront payment of around $102 per share and an additional $12.50 …

Lantheus Holdings Inc (LNTH) Cash Flow

This article provides a detailed cash flow statement for Lantheus Holdings Inc (LNTH), broken down into operating, investing, and financing activities on a quarterly and annual basis. It includes historical data spanning many years, along with year-over-year percentage changes. The piece also features a …

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 7.17% Potential Upside in the Healthcare Sector

Lantheus Holdings Inc. (LNTH), a healthcare company specializing in diagnostic and therapeutic products, shows a potential upside of 7.17% according to analyst ratings. The company maintains a market capitalization of $6.82 billion, a forward P/E of 16.64, and strong financial health with $421.7 million …

Curium in Talks to Acquire Lantheus For $7 Billion

Curium is reportedly in discussions to acquire Lantheus Holdings, Inc. for $7 billion. This potential acquisition follows recent news of Lantheus weighing a sale after Curium's initial offer. Lantheus specializes in radiopharmaceuticals for diagnostics and treatment in areas like oncology, neurology, and cardiology.

Lantheus Holdings Inc (LNTH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Lantheus Holdings Inc (LNTH), detailing its performance by business segments such as PYLARIFY, DEFINITY, TechneLite, Strategic partnerships, and Neuraceq. It presents financial data across multiple fiscal years and quarters, highlighting each segment's revenue contribution. The report indicates …

Lantheus Holdings Inc Revenue Breakdown – XETR:0L8

Lantheus Holdings Inc (XETR:0L8) generated 1.31 billion EUR in revenue last year, with its top-performing segment, PYLARIFY, contributing 842.15 million EUR. The United States was the primary regional contributor, accounting for 1.24 billion EUR of the company's revenue. This financial breakdown highlights the company's …

LNTH|Lantheus Holdings Inc|Price:104.820|Chg%:+1.090

Lantheus Holdings Inc (LNTH) is trading at $104.82, up 1.05%, with a market cap of $6.82 billion. The company exhibits strong fundamentals and high growth potential, though its valuation is considered fairly valued within the Healthcare Equipment & Supplies industry. Analysts largely rate it …

HRG5717197 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the Lantheus Holdings, Inc. 2.625% 15-DEC-2027 bond (HRG5717197). It details the current coupon rate of 2.63% and notes that the next interest payment is scheduled for December 15, 2026. The content also mentions the availability of more …

Lantheus to Host Q2 2026 Earnings Call and Webcast on Aug 6

Lantheus Holdings, Inc. (NASDAQ: LNTH) announced it will host its Q2 2026 earnings call and webcast on August 6, 2026, at 8:00 a.m. ET to discuss financial results and provide business updates. Investors are encouraged to register online, and a replay will be available …

Lantheus (LNTH) Stock Still Looks Fairly Priced On Earnings Strength

Lantheus Holdings (LNTH) stock has seen a significant 287.3% return over the past five years and is currently trading around US$104.61. While its strong performance and valuation checks suggest it's fairly priced rather than overtly cheap or stretched, its P/E ratio is slightly below …

Lantheus Schedules Aug. 6 Webcast and Business Update

Lantheus (NASDAQ: LNTH) announced it will host its second quarter 2026 earnings conference call and webcast on Thursday, August 6, 2026, at 8:00 a.m. Eastern Time. The event will cover the company's financial results and provide a business update for the quarter. Individuals are …

HRG5717197 Bond Profile — Key Metrics

This article provides a detailed profile of the Lantheus Holdings, Inc. 2.625% 15-DEC-2027 bond, identified as HRG5717197. It outlines key bond metrics such as the issue and maturity dates, outstanding amount, face value, and coupon rate. The profile also includes a description of Lantheus …

LANTHEUS HOLDINGS INC : TD COWEN RAISES TARGET PRICE TO $110 FROM $105

TD Cowen has raised its target price for Lantheus Holdings Inc (LNTH.O) to $110 from $105. This adjustment reflects an updated outlook from the analytical firm regarding the company's valuation. The article states that this content solely reflects the author's opinion and is not …

(LNTH) Movement as an Input in Quant Signal Sets

This article analyzes Lantheus Holdings Inc. (NASDAQ: LNTH) using AI models, revealing divergent sentiment across various time horizons and suggesting choppy market conditions. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—each tailored to different risk profiles and optimized with sophisticated risk …

Lantheus Holdings Inc (LNTH) Q1 2024 Earnings Report - Results, Call & Slides

Lantheus Holdings Inc (LNTH) reported strong Q1 2024 earnings, beating analyst expectations with an actual EPS of $1.69 against a consensus of $1.54, and actual revenue of $369.98 million compared to an expected $349.25 million. The company achieved a 23.00% year-over-year revenue growth. The …

LANTHEUS HOLDINGS INC : TRUIST SECURITIES RAISES TARGET PRICE TO $125 FROM $115

Truist Securities has increased its target price for Lantheus Holdings Inc (LNTH.O) to $125 from $115. The information, disseminated by Reuters, indicates an updated analyst outlook for the company's stock. It's important to note this content reflects the author's opinion and is not investment …

Lantheus Holdings (LNTH) Could Be 2% Undervalued Following Its Alzheimer Imaging Narrative

Lantheus Holdings (LNTH) is gaining attention due to strong stock performance and its Alzheimer's imaging franchise, including the FDA-approved Neuraceq and the late-stage tau radiodiagnostic MK-6240. Despite a 2% undervaluation according to a prevailing narrative, the company faces potential challenges from pricing pressure in …

Lantheus Holdings Is Maintained at Market Outperform by Mizuho

Mizuho has reiterated its "Market Outperform" rating on Lantheus Holdings (LNTH). The analyst has also maintained a price target of $105.00 for the company.

Lantheus (LNTH) Considers Sale Following Curium Acquisition Prop

We Think You Should Be Aware Of Some Concerning Factors In Lantheus Holdings' (NASDAQ:LNTH) Earnings

Lantheus Holdings (LNTH) Valuation Check After Q1 Earnings Beat And FDA Approval Catalysts

Lantheus (NASDAQ:LNTH) Surprises With Q1 CY2026 Sales

Earnings call transcript: Lantheus Holdings Q1 2026 beats forecasts, stock rises

Assessing Lantheus Holdings (LNTH) Valuation After Recent Share Price Rebound And PYLARIFY Outlook

LNTH: 2025 Earnings Flash Report